eHIV Review eHIV Review

Hosted on Acast. See acast.com/privacy for more information.

Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their engagement in HIV care? What do health care providers need to change to minimize stigma in their practices? 
These are some of the questions advanced practice nurse Dallas Ducar, CEO of Transhealth, discusses in this issue of eHIV Review. 
Take our post-test to claim CME credits.
To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?
Which drug combinations are right? Where does the balance between side effects and adherence lie?
These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.
Take our post-test to claim CME credits.
To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain? How can patients most at risk for weight-related comorbidities be identified? 
Join us as we discuss these and other issues with Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University, in this eHIV Review podcast. 
Take our post-test to claim CME credits.
To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?
Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.
Take our post-test to claim CME credits.
To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?
Join us for this eHIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questions
Take our post-test to claim CME credits.
To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.